Connect development, analytical and manufacturing data to accelerate filings and tech transfer
Unify process development, analytical and manufacturing data with IDBS Polar and IDBS PIMS—reducing filing preparation time, strengthening tech transfer and maintaining regulatory defensibility across the entire CMC lifecycle. Our purpose-built CMC solution delivers structured, contextualized data from bench to batch.
For CMC leaders, the pressure to compress timelines from IND to BLA without increasing risk has never been greater.
Development data often lives in disconnected systems, instruments and teams, making it hard to preserve context, maintain traceability and confidently transfer processes between stages and sites. Critical process knowledge walks out the door when scientists move on. And when it’s time for tech transfer or regulatory filing, teams spend months manually reconstructing development histories that should have been captured from the start.
The result? Delayed filings. Incomplete traceability. Risk that’s hard to quantify—and harder to defend in front of regulators.
How does the IDBS CMC solution address these challenges?
From bench to batch—structured, contextualized data without the manual handoff
IDBS Polar and IDBS PIMS together form one continuous CMC data thread—from bench to batch. Polar captures and contextualizes process development data at the point of creation, while PIMS unifies manufacturing process and quality data for compliance and insight. The result is structured, traceable data without manual handoff.
Capture and contextualize development data across the CMC lifecycle
Polar is an enterprise lab informatics platform combining ELN, LES and LIMS capabilities in a single GxP-compliant environment. For CMC teams, Polar captures structured process knowledge as development decisions are made—from cell line development and process characterization through analytical method development and formulation studies.
This means your development rationale, experimental context and data lineage are preserved and ready for downstream use, whether that’s tech transfer packages, regulatory filings or AI-driven analytics.
Unify manufacturing process and quality data for compliance and insight
IDBS PIMS is a cloud-native software platform that provides a contextualized data backbone of critical manufacturing processes and quality data across products and batches while supporting 21 CFR Part-11 compliance needs. PIMS consumes Polar’s structured process definitions, harmonizing CMC data across the lifecycle, simplifying CPP alignment and supporting CPV readiness and APQR filings from the first commercial batch.
Most organizations lose months reconstructing development knowledge for manufacturing handoff. With the IDBS CMC solution, tech transfer is accelerated because the data thread is maintained. Process characterization data flows from development to manufacturing with full context—no manual reconciliation, no lost institutional knowledge, no regulatory surprises.
See how Polar and PIMS deliver outcomes at every stage—from cell line development through commercial manufacturing. Structured, contextualized data from bench to batch accelerates timelines, reduces risk and strengthens regulatory defensibility.
In many BioPharma organizations, CMC data is scattered across experiments, instruments, spreadsheets and teams rarely structured or contextualized in a way that supports confident decision-making, regulatory submission or AI-driven analytics.
As data moves through the development lifecycle, critical context, metadata and provenance are lost, and lineage breaks across wet lab, dry lab and downstream environments. The result is slower development cycles, costly reconciliation efforts and data that can’t be trusted when it matters most.
The IDBS CMC solution addresses this at the point of origin—capturing, connecting and contextualizing data as it is generated, so it remains accurate, traceable and actionable throughout the entire development journey.
Together, these capabilities translate into faster development timelines, reduced risk of regulatory delay and more informed decisions at every stage—from early development through to submission.
IDBS is purpose-built for BioPharma CMC. Here’s what sets IDBS apart from generic lab informatics tools.
From global pharma to breakthrough cell therapy platforms—see how IDBS customers are accelerating CMC timelines and strengthening data integrity across their development and manufacturing operations.
A global biosimilars company needed to eliminate inefficient, paper-based laboratory data management across multiple development and analytical functions. Manual data recording was driving transcription errors, rework cycles and lost researcher time—while increasing paper consumption and storage needs.
The company chose IDBS Polar as its GxP-compliant SaaS platform to digitize and standardize laboratory execution across >400 users, >250 workflows and 358 connected instruments and systems. Key outcomes included ~50% fewer incidents from manual transcription errors and tens of hours per researcher per year returned to science.
This story demonstrates Polar’s ability to unify data capture and instrument integration across the breadth of CMC functions—from process development to analytics—delivering measurable quality and efficiency gains at scale through a single platform.
A top five global CDMO needed to replace disconnected spreadsheets and email-based communication with drug sponsors. Inconsistent data formats across process engineers, no secondary data checks, and poor visibility into batch performance were hindering fast decision-making — impacting the ability to proactively monitor processes, catch deviations early, prevent batch failure and streamline CPV reporting. For CMC and manufacturing leaders, this is a familiar pain point: critical process data exists, but it’s trapped in silos, making it impossible to see trends, act on signals in real time or demonstrate control to regulators and sponsors with confidence.
The CDMO chose cloud-based IDBS PIMS as a single system to standardize manufacturing data collection and process monitoring across multiple sites and products. PIMS replaced manual, spreadsheet-driven workflows with automated data aggregation, real-time statistical process monitoring and configurable control charts — giving process engineers and quality teams immediate visibility into batch trends and out-of-spec signals. It also enabled real-time batch data sharing with sponsors, faster deviation investigations and more efficient CPV reporting — with expected cost savings equivalent to nearly 13,000 hours per year across all teams.
This story shows how IDBS PIMS directly addresses one of the biggest pain points in commercial manufacturing: the gap between collecting process data and being able to act on it. By replacing fragmented spreadsheets with a validated, sponsor-accessible platform that delivers real-time process monitoring and trend analysis, PIMS helps CMC leaders move from reactive firefighting to proactive process control — protecting product quality, accelerating decision-making and simplifying regulatory reporting at commercial scale.
Vantive, a vital organ therapy company with a 70-year legacy of kidney care innovation, needed to move from fragmented, on-premise systems to a unified, cloud-based ecosystem. A multi-site rollout across North America, Europe and Asia required standardized data, processes and governance to harmonize global operations and accelerate time-to-market.
Vantive chose IDBS Polar as their modern digital foundation—a single GxP-compliant informatics platform to connect global data and workflows across the therapy development lifecycle. IDBS was selected for its global experience in enterprise software deployments across multiple sites, deep domain expertise and its trusted partnership approach.
Vantive’s story validates IDBS Polar as a platform for global-scale CMC digital transformation — connecting development data and workflows across continents with consistent standards and governance.
The Technical Research & Development (TRD) division of a Top 20 global pharma company needed an end-to-end solution to address global complexity across multiple modalities in four countries, fragmented lab systems with disparate ELNs and lab tools, and critical business needs for data integrity, traceability, seamless integration and scalable digital transformation.
IDBS Polar stood out for its unmatched capability across 15 complex use cases—spanning Cell Therapy, Gene Therapy, Biologics, Development, Bioanalytical and more—plus a unified SaaS platform (ELN + LES with no-code workflows), scalable and configurable architecture aligned with company IT and data architecture, and a trusted partnership built on deep domain expertise and a collaborative approach.
When a Top 20 pharma evaluates 15 complex CMC use cases across four countries and multiple modalities — and selects a single platform—that’s the strongest possible validation of Polar’s enterprise CMC capability.
As processes move from development to manufacturing, disconnected systems can erode critical process knowledge. This on‑demand webinar explores how a process‑centric digital approach preserves context, captures decisions in real time, and simplifies tech transfer across the CMC lifecycle.
Understand how process-focused digital systems overcome the limitations of traditional ELN and LIMS tools in this Ask the Expert webinar with Marc Smith, Lead Product Manager, Process Development at IDBS.
As BioPharma organizations accelerate drug development, integrating structured process knowledge with AI is becoming a strategic imperative. In this session, Marc Smith, Lead Product Manager for Process Development at IDBS, introduces how the Polar platform—along with the newly launched Polar Control module—enables a process-focused digital approach.
The BioPharma industry is rapidly embracing digital transformation, with data-driven decision-making at its core. Generative AI (GenAI) and Large Language Models (LLMs) are becoming strategic priorities for accelerating the development of life-changing therapies. However, leveraging these technologies effectively requires high-quality, structured data, especially in Chemistry, Manufacturing, and Controls (CMC) workflows.
Talk to a CMC specialist about how Polar and PIMS can accelerate your development timelines and strengthen regulatory readiness.
Learn the importance of data integration and management in biopharmaceutical development, and how IDBS’ solutions can improve decision-making.
Talk on “Streamlining upstream development: an integrated digital backbone to combine product and process insight for a more efficient path to success.”
IDBS cut cell line development reporting timelines by 50%. It supports hundreds of users globally at a biotechnology company focusing on biologic therapeutics.
*Customer data on file at IDBS for IDBS PIMS
** Based on results seen with IDBS E-Workbook. IDBS Polar delivers the same or higher gains as IDBS E-Workbook in a like-for-like implementation, with added value from advanced analytics, AI/ML and reporting.
